273 related articles for article (PubMed ID: 26147484)
1. Liquid chromatography/tandem mass spectrometry study of forced degradation of azilsartan medoxomil potassium.
Swain D; Patel PN; Palaniappan I; Sahu G; Samanthula G
Rapid Commun Mass Spectrom; 2015 Aug; 29(15):1437-47. PubMed ID: 26147484
[TBL] [Abstract][Full Text] [Related]
2. Forced degradation, LC-UV, MS(n) and LC-MS-TOF studies on azilsartan: Identification of a known and three new degradation impurities.
Kaushik D; Kaur J; Paul Kaur V; Saini B; Bansal Y; Bansal G
J Pharm Biomed Anal; 2016 Feb; 120():202-11. PubMed ID: 26752083
[TBL] [Abstract][Full Text] [Related]
3. Identification of forced degradation products of tamsulosin using liquid chromatography/electrospray ionization tandem mass spectrometry.
Namdev D; Borkar RM; Raju B; Kalariya PD; Rahangdale VT; Gananadhamu S; Srinivas R
J Pharm Biomed Anal; 2014 Jan; 88():245-55. PubMed ID: 24083958
[TBL] [Abstract][Full Text] [Related]
4. Identification of hydrolytic and isomeric N-oxide degradants of vilazodone by on line LC-ESI-MS/MS and APCI-MS.
Kalariya PD; Talluri MV; Patel PN; Srinivas R
J Pharm Biomed Anal; 2015 Jan; 102():353-65. PubMed ID: 25459935
[TBL] [Abstract][Full Text] [Related]
5. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of azilsartan and chlorthalidone in rat and human plasma by liquid chromatography-electrospray tandem mass spectrometry.
Ramakrishna R; Puttrevu SK; Bhateria M; Bala V; Sharma VL; Bhatta RS
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 990():185-97. PubMed ID: 25899870
[TBL] [Abstract][Full Text] [Related]
7. Characterization of degradation products of silodosin under stress conditions by liquid chromatography/Fourier transform mass spectrometry.
Pandeti S; Narender T; Prabhakar S; Reddy TJ
Rapid Commun Mass Spectrom; 2017 Mar; 31(6):572-582. PubMed ID: 28063187
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of stressed degradation products of metoprolol using LC/Q-TOF-ESI-MS/MS and MS(n) experiments.
Borkar RM; Raju B; Srinivas R; Patel P; Shetty SK
Biomed Chromatogr; 2012 Jun; 26(6):720-36. PubMed ID: 21989963
[TBL] [Abstract][Full Text] [Related]
9. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction.
Kalariya PD; Raju B; Borkar RM; Namdev D; Gananadhamu S; Nandekar PP; Sangamwar AT; Srinivas R
J Mass Spectrom; 2014 May; 49(5):380-91. PubMed ID: 24809899
[TBL] [Abstract][Full Text] [Related]
10. LC/Q-TOF-MS-based structural characterization of enasidenib degradation products and establishment of a stability-indicating assay method: Insights into chemical stability.
Chakkar A; Chaturvedi S; Rajput N; Sengupta P; Sharma N
Rapid Commun Mass Spectrom; 2024 Mar; 38(5):e9696. PubMed ID: 38355880
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
[TBL] [Abstract][Full Text] [Related]
12. Selective separation and characterization of the stress degradation products of ondansetron hydrochloride by liquid chromatography with quadrupole time-of-flight mass spectrometry.
Talluri MV; Keshari KK; Kalariya PD; Srinivas R
J Sep Sci; 2015 May; 38(10):1625-32. PubMed ID: 25727389
[TBL] [Abstract][Full Text] [Related]
13. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
[TBL] [Abstract][Full Text] [Related]
14. Stability-indicating RP-LC method for determination of azilsartan medoxomil and chlorthalidone in pharmaceutical dosage forms: application to degradation kinetics.
Ebeid WM; Elkady EF; El-Zaher AA; El-Bagary RI; Patonay G
Anal Bioanal Chem; 2014 Oct; 406(26):6701-12. PubMed ID: 25190009
[TBL] [Abstract][Full Text] [Related]
15. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis.
Patel PN; Borkar RM; Kalariya PD; Gangwal RP; Sangamwar AT; Samanthula G; Ragampeta S
J Mass Spectrom; 2015 Feb; 50(2):344-53. PubMed ID: 25800016
[TBL] [Abstract][Full Text] [Related]
16. Liquid chromatography electrospray ionization tandem mass spectrometry study of nilutamide and its stress degradation products: in silico toxicity prediction of degradation products.
Ramesh Babu A; Borkar RM; Raju G; Raju B; Srinivas R
Biomed Chromatogr; 2014 Jun; 28(6):788-93. PubMed ID: 24861745
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of stress degradation products of sumatriptan succinate by using LC/Q-TOF-ESI-MS/MS and NMR: Toxicity evaluation of degradation products.
Udutha S; Shankar G; Borkar RM; Kumar K; Srinivasulu G; Guntuku L; Naidu VGM; Srinivas R
J Mass Spectrom; 2018 Oct; 53(10):963-975. PubMed ID: 29987857
[TBL] [Abstract][Full Text] [Related]
18. LC-ESI-MS/MS evaluation of forced degradation behaviour of silodosin: In vitro anti cancer activity evaluation of silodosin and major degradation products.
Vishnuvardhan C; Saibaba B; Allakonda L; Swain D; Gananadhamu S; Srinivas R; Satheeshkumar N
J Pharm Biomed Anal; 2017 Feb; 134():1-10. PubMed ID: 27866053
[TBL] [Abstract][Full Text] [Related]
19. Isolation, characterization using LC-ESI-QTOF, NMR and in vitro cytotoxicity assay of niclosamide forced degradation products.
P J; Ch V; A L; V G M N; Ch N; N S
J Pharm Biomed Anal; 2017 Mar; 136():148-155. PubMed ID: 28081501
[TBL] [Abstract][Full Text] [Related]
20. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
